Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for X4 Pharmaceuticals, Inc Common Stock (XFOR).
- Disclosed ownership: 10%.
- Date of event: 28 Feb 2026.
MORGAN STANLEY - 28 Feb 2026 SCHEDULE 13G/A Report for X4 Pharmaceuticals, Inc Common Stock (XFOR)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Security
- X4 Pharmaceuticals, Inc Common Stock
- Symbol
- XFOR
- Shares outstanding
- 87,101,353 shares
- Disclosed Ownership
- 8,884,338 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Mar 2026, 16:24:18 UTC
- Date of event
- 28 Feb 2026
- Previous filing
- 12 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 10% ownership in X4 Pharmaceuticals, Inc Common Stock (XFOR) on 28 Feb 2026."
What Changed
- Previous schedule filing date: 12 Feb 2026.
- Current filing was accepted on 06 Mar 2026, 16:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 10% | 8,884,338 | 0 | 8,884,338 | Claire Gordon | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Investment Management Inc. | 10% | 8,884,304 | 0 | 8,884,304 | Deidre A. Downes | Authorized Signatory, Morgan Stanley Investment Management Inc. | |
| Inception Trust | 5.2% | 4,518,236 | 0 | 4,518,236 | Deidre A. Downes | Authorized Signatory, Inception Trust |